COST-EFFECTIVENESS REVIEWS BY HTA AGENCIES: A COMPARISON OF FACTORS LEADING TO UNFAVOURABLE REVIEWS FOR ONCOLOGY AGENTS

被引：0
|
作者：
Smith, N. [1 ]
Beckerman, R. [1 ]
机构：
[1] CBPartners, New York, NY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.048
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HT4
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews
    Farbod Ebadifard Azar
    Saber Azami-Aghdash
    Fatemeh Pournaghi-Azar
    Alireza Mazdaki
    Aziz Rezapour
    Parvin Ebrahimi
    Negar Yousefzadeh
    BMC Health Services Research, 17
  • [22] Results of a systematic Reviews on the Effectiveness and Cost-Effectiveness of Innovative Care Management Approaches for the Treatment of Multiple Sclerosis
    Ochs, A.
    Weegen, L.
    Korff, L.
    Walendzik, A.
    Jahn, R.
    Neumann, A.
    Wasem, J.
    Mostardt, S.
    GESUNDHEITSWESEN, 2012, 74 (8-9) : 576 - 576
  • [23] Use of cost-effectiveness analysis to compare the efficiency of study identification methods in systematic reviews
    Shemilt I.
    Khan N.
    Park S.
    Thomas J.
    Systematic Reviews, 5 (1)
  • [24] Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews
    Azar, Farbod Ebadifard
    Azami-Aghdash, Saber
    Pournaghi-Azar, Fatemeh
    Mazdaki, Alireza
    Rezapour, Aziz
    Ebrahimi, Parvin
    Yousefzadeh, Negar
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [25] Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis
    Coleman, T.
    Agboola, S.
    Leonardi-Bee, J.
    Taylor, M.
    McEwen, A.
    McNeill, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (49) : 1 - +
  • [26] Effectiveness and Cost-Effectiveness of eHealth Interventions in Somatic Diseases: A Systematic Review of Systematic Reviews and Meta-Analyses
    Elbert, Niels J.
    van Os-Medendorp, Harmieke
    van Renselaar, Wilco
    Ekeland, Anne G.
    Hakkaart-van Roijen, Leona
    Raat, Hein
    Nijsten, Tamar E. C.
    Pasmans, Suzanne G. M. A.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2014, 16 (04) : 182 - 204
  • [27] A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
    Vakaramoko Diaby
    Rima Tawk
    Vassiki Sanogo
    Hong Xiao
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2015, 151 : 27 - 40
  • [28] COMPARISON OF THE USE OF REAL-WORLD EVIDENCE (RWE) BY HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES IN REVIEWS OF DRUGS FOR RARE DISEASES (DRDS)
    Kirby, J.
    Tadros, N.
    Gosain, S.
    VALUE IN HEALTH, 2023, 26 (12) : S508 - S508
  • [29] REIMBURSEMENT DECISION LANDSCAPE FOR METASTATIC BREAST CANCER THERAPIES: A COMPARISON OF FACTORS LEADING TO FAVORABLE AND UNFAVORABLE RECOMMENDATIONS ACROSS LEADING HTA AGENCIES
    Banerjee, P.
    Gupta, J.
    Kumar, P.
    Kapoor, A.
    Mazumder, D.
    VALUE IN HEALTH, 2015, 18 (03) : A6 - A6
  • [30] A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
    Diaby, Vakaramoko
    Tawk, Rima
    Sanogo, Vassiki
    Xiao, Hong
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) : 27 - 40
12345